Clinical trial
Phase II Trial of Ontak With Metastatic Melanoma
NCT00299689 · James Graham Brown Cancer Center, Other · Completed
Key facts
| NCT number | NCT00299689 |
|---|---|
| Title | Phase II Trial of Ontak With Metastatic Melanoma |
| Official title | Phase II Trial of ONTAK With Metastatic Melanoma |
| Lead sponsor | James Graham Brown Cancer Center, Other |
| Collaborators | University of Louisville |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Melanoma |
| Intervention type | Drug |
| Interventions | Denileukin diftitox |
| Enrollment | 69 |
| Start date | Mar 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Mar 7, 2006 |
| Last update posted | Sep 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: